Skip to content

A Study on the Correlation Between Cardiac Autonomic Nervous Function and Quality of Life in Patients with Coronary Heart Disease

A Study on the Correlation Between Cardiac Autonomic Nervous Function and Quality of Life in Patients with Coronary Heart Disease: An Exploratory Intervention Based on the Yao Ethnic Group’s Five-Tone Music Therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099438
Enrollment
Unknown
Registered
2025-03-24
Start date
2025-03-26
Completion date
Unknown
Last updated
2025-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Heart Disease

Interventions

Intervention Group:Conventional treatment combined with Yao ethnic five-tone therapy
Control group:Receive conventional treatment

Sponsors

Guidong People’s Hospital of Guangxi Zhuang Autonomous
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-75 years old, diagnosed coronary heart disease and in stable stage (including more than 3 months after PCI or only drug treatment); 2. NYHA cardiac function grade I-II, which can be combined with music intervention; 3. No severe hearing impairment or mental cognitive impairment; 4. Sign the informed consent form, voluntarily participate in the trial and can be followed up on time.

Exclusion criteria

Exclusion criteria: 1. Presence of other serious organic diseases (such as advanced malignant tumors, severe liver and kidney insufficiency, etc.); 2. Patients with significant affective disorders (manic episodes, severe mental illness) or music allergies and intolerance; 3. Conditions that are judged to be unsuitable for continuation during the study period (such as major emergencies such as acute myocardial infarction).

Design outcomes

Primary

MeasureTime frame
Autonomic Nervous Function Assessment Indicators;Quality of Life Assessment Indicators;

Secondary

MeasureTime frame
Psychological Status and Subjective Experience;Safety and Adverse Reaction Monitoring;

Countries

China

Contacts

Public ContactCen Kaiyuan

Guidong People’s Hospital of Guangxi Zhuang Autonomous

cky163163@163.com+86 158 0774 2254

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026